Arizona

Overview

Arizona legalized medical cannabis in 2010 via Proposition 203 (50.1%) and adult-use cannabis in 2020 via the Smart and Safe Arizona Act (Proposition 207, 60%). Licensed adult-use retail sales began January 22, 2021, one of the fastest medical-to-recreational rollouts in the United States. The fast launch was accelerated by Arizona's pre-existing licensed-dispensary infrastructure.

Both programs are administered by the Arizona Department of Health Services (ADHS) Medical Marijuana Program division. Adult-use rules are codified at A.R.S. Title 36 Chapter 28.2, medical at Chapter 28.1.

Adult-use (Proposition 207, 2020)

• Public possession: up to 1 oz of cannabis flower, of which no more than 5 g may be concentrate.
• Home cultivation: up to 6 plants per adult; maximum 12 plants per household with two or more adult residents.
• Tax: 16% excise on adult-use sales. Revenue funds law enforcement, community colleges (33%), and highway infrastructure.

Medical program (Proposition 203, 2010)

Qualifying conditions

A.R.S. § 36-2801 enumerates the qualifying conditions, including:

• Cancer, glaucoma, HIV/AIDS, hepatitis C, ALS, Crohn's disease, Alzheimer's disease
• Cachexia / wasting syndrome
• Severe and chronic pain
• Severe nausea
• Seizures (including epilepsy)
• Severe and persistent muscle spasms (including MS)
• PTSD

Patient access

• Possession: up to 2.5 oz of cannabis per 14-day supply.
• Approved forms: flower, edibles, oils, tinctures, capsules, topicals, vapes.
• Home cultivation: medical patients may cultivate 12 plants; but only if their residence is more than 25 miles from an operating dispensary. This geographic restriction substantially limits patient cultivation in metro Phoenix and Tucson.
• Dispensary cap: Arizona limits total medical dispensary licenses to 124 statewide.

Reciprocity

Arizona is one of the more permissive reciprocity jurisdictions: visiting patients with valid out-of-state medical cannabis registration may possess medical-use cannabis under Arizona law, though they cannot purchase from Arizona medical dispensaries without an Arizona registry card. Visiting patients aged 21+ may purchase from any adult-use retailer.

Patients and caregivers

• Patient minimum age: no statutory floor. Minor patients require physician certification and a designated caregiver (parent or legal guardian).
• Caregiver minimum age: 21.
• Caregivers per caregiver: a single caregiver may serve up to 5 patients.
• Caregiver registration: via ADHS; criminal background check.

Patient registration steps

1. Schedule a visit with an Arizona-licensed physician, naturopath, homeopath, or osteopath willing to certify a qualifying condition. The certifying provider must establish a bona fide patient-provider relationship and document the qualifying condition.
2. The provider submits a written certification through the ADHS Medical Marijuana Program portal.
3. The patient applies through the ADHS portal, submits identity documents, proof of Arizona residency, and a current photo. The standard application fee is $150 (one year) or $300 (two years). Reduced fees apply for SNAP recipients.
4. Approved patients receive an ADHS Registry ID Card valid for one or two years. The card authorizes purchases at any licensed Arizona dispensary, the medical-program supply caps, and home-cultivation rights subject to the 25-mile rule.

Minor patients require physician certification and a designated caregiver (parent or legal guardian). The caregiver completes a separate application and Arizona Department of Public Safety background check.

Reciprocity and visiting patients

Arizona's framework is dual-track for visitors with a notable possession-protection nuance:

• Adult-use: any visitor 21 or older with a government-issued photo ID may purchase from a licensed adult-use retailer under the 1 oz / 5 g concentrate cap.
• Medical possession reciprocity: Arizona recognizes valid out-of-state medical-cannabis cards for the purpose of possession protection. Visiting patients may possess medical-quantity cannabis under Arizona law.
• Medical purchase: out-of-state cardholders cannot purchase from Arizona medical dispensaries (which would require an Arizona Registry ID Card). Visiting patients access cannabis through the adult-use retail framework.

The possession-protection reciprocity is unusual; most reciprocity-friendly states extend either both possession and purchase or neither. Arizona's split framework reflects the structural separation between the 2010 medical program and the 2020 adult-use overlay.

Employment and workplace

Arizona provides moderate employment protections under the Arizona Medical Marijuana Act and the Smart and Safe Arizona Act, with carve-outs:

• Patient discrimination: the Medical Marijuana Act prohibits adverse employment action against an employee solely based on medical patient status, with safety-sensitive exceptions.
• Off-duty use: adult-use protections are narrower than in some legalized states; employers retain broad discretion.
• Federal contractor and DOT-regulated positions: federal drug-free workplace and DOT testing rules supersede state-level protection.
• Safety-sensitive positions: employers may continue to enforce drug-free workplace policies for safety-sensitive roles.
• Workers' compensation: post-incident testing positive for THC may affect benefits.

Arizona case law has tested the safety-sensitive boundary in litigation since 2019. Public-employee positions, healthcare licensing, and CDL holders face additional licensing-board exposure beyond employer discipline.

Hemp-derived intoxicants

Arizona has not enacted comprehensive restrictions on hemp-derived intoxicating cannabinoids as of mid-2026. Retail availability of delta-8 THC, delta-10 THC, THC-O, and HHC products has been substantial through gas-station, vape-shop, and dedicated hemp-retailer channels. Legislative attention has increased; the 2025 and 2026 sessions considered restrictions without enactment.

Recent legislative and regulatory history

Notable developments:

• 2010: Proposition 203 (medical cannabis) approved.
• 2012-2013: dispensary licensing rolled out; first medical retail began.
• 2020: Proposition 207 (adult-use legalization) approved.
• 2021: licensed adult-use retail sales began January 22.
• 2023-2024: Department of Health Services rulemaking refined possession-cap calculations, dispensary licensing rules, and social-equity license categories.
• 2025-2026: continued legislative work on advertising restrictions, hemp-derived intoxicant regulation, and dispensary licensing caps.

The April 2026 federal Schedule III rescheduling order produced no immediate Arizona legislative response.

Tribal jurisdiction

Arizona includes 22 federally recognized tribal nations, several of which have established tribal cannabis frameworks. The San Carlos Apache Tribe, Pascua Yaqui Tribe, Tohono O'odham Nation, and Salt River Pima-Maricopa Indian Community have engaged in tribal cannabis governance discussions or operations. Tribal jurisdiction is distinct from state jurisdiction; cannabis transported off tribal land onto state or federal land is subject to applicable non-tribal law.

Federal context

Federal jurisdiction layers additional exposure on federal land, federal courthouses, military installations (Davis-Monthan Air Force Base, Luke Air Force Base, Yuma Proving Ground, Fort Huachuca, MCAS Yuma), and interstate highways. Grand Canyon National Park, Saguaro National Park, Petrified Forest National Park, and substantial Bureau of Land Management and US Forest Service land fall under federal cannabis prohibition regardless of state authorization. I-8, I-10, I-15, I-17, I-19, and I-40 corridors see active state-patrol and federal drug-interdiction activity, particularly at the California, Nevada, Utah, and New Mexico borders. The Mexican border south of Tucson and Yuma sees intensive US Customs and Border Protection cannabis-enforcement activity.